Brain-derived neurotrophic factor secreted by the cerebral endothelium: A new actor of brain function?. Issue 6 (June 2018)

• Record Type: Journal Article
• Authors: Marie, Christine; Pedard, Martin; Quirié, Aurore; Tessier, Anne; Garnier, Philippe; Totoson, Perle; Demougeot, Céline
• Is Part Of: Journal of cerebral blood flow & metabolism. Volume 38:Issue 6(2018)
• Page Start: 935
• Page End: 949
• Publication Date: 2018-06
• Subjects: Brain-derived neurotrophic factor -- cerebral endothelium -- cognition -- nitric oxide -- tropomyosin-related kinase B; Cerebral circulation -- Periodicals; Brain -- Metabolism -- Periodicals; Brain -- Blood-vessels -- Periodicals; Cerebrovascular disease -- Periodicals; 612.824
• DOI: 10.1177/0271678X18766772
• Languages: English
• ISSNs: 0271-678X

Abstract

Low cerebral levels of brain-derived neurotrophic factor (BDNF), which plays a critical role in many brain functions, have been implicated in neurodegenerative, neurological and psychiatric diseases. Thus, increasing BDNF levels in the brain is considered an attractive possibility for the prevention/treatment of various brain diseases. To date, BDNF-based therapies have largely focused on neurons. However, given the cross-talk between endothelial cells and neurons and recent evidence that BDNF expressed by the cerebral endothelium largely accounts for BDNF levels present in the brain, it is likely that BDNF-based therapies would be most effective if they also targeted the cerebral endothelium. In this review, we summarize the available knowledge about the biology and actions of BDNF derived from endothelial cells of the cerebral microvasculature and we emphasize the remaining gaps and shortcomings.